FDA
Biotech

AACR: Pazdur bemoans state of FDA, warns of political influence

Asked by Fierce if he'd consider returning to the FDA, Pazdur said he wouldn't serve again under the Trump administration "for obvious reasons."
Darren Incorvaia Apr 18, 2026 4:00am
magic mushroom

Trump orders FDA to fast-track reviews of psychedelic drugs

Apr 20, 2026 5:30am
Yu Lu-Fierce Biotechjpg

How WuXi AppTec’s Integrated Platform Is Helping Therapies Move Faster from Discovery to Patients

Brought to you by WuXi AppTec
Person riding bike down road

AACR: Genentech veteran engineers ‘smart’ cancer drug startup

Apr 19, 2026 6:05pm
Beagle wearing a party hat next to a cake with a candle for its first birthday

FDA celebrates animal testing shift as experts eye road ahead

Apr 19, 2026 6:00pm
merck

AACR: Merck unveils PD-1xVEGF bispecific data in NSCLC

Apr 17, 2026 3:00pm
More News

UCB strikes $1.15B deal for cell therapy biotech Neurona

Apr 17, 2026 1:55pm

Metsera sale architect swings to Structure—Chutes & Ladders

Apr 17, 2026 10:10am

OpenAI launches biotech-specific AI model dubbed GPT-Rosalind

Apr 17, 2026 10:00am

Roivant’s CEO thinks China is a ‘red herring’

Apr 17, 2026 8:35am